| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sagimet Biosciences Inc. (SGMT) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. SGMT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 741.6K | $6.41M | -64,051 | |
| Other | 224.4K | $1.94M | -10,545 | |
| Dir | 62.2K | $537.1K | -18,844 | |
| CFO | 50.0K | $432.0K | - | |
| Other | 35.0K | $302.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | Kemble George | Director | Sell | 18,844 | $7.46 | $140,529.13 | -23.3% | - | - | |
| Jul 20, 2026 | Rozek Elizabeth | Chief Legal &Admin. Officer | Sell | 10,545 | $7.76 | $81,832.36 | -4.5% | - | - | |
| Jul 20, 2026 | Happel David71 | President &CEO | Sell | 64,051 | $7.76 | $497,067.79 | -8.0% | - | - | |
| Nov 20, 2025 | Kemble George | Executive Chairman | Sell | 37,688 | $7.69 | $289,979.01 | -31.8% | -27.8% | - | |
| Jul 21, 2025 | Happel David71 | President &CEO | Sell | 65,478 | $9.13 | $598,115.34 | -8.7% | -11.3% | -13.4% | |
| Jul 21, 2025 | Martins Eduardo Bruno | Chief Medical Officer | Sell | 8,277 | $9.13 | $75,607.08 | -7.2% | -11.3% | -13.4% | |
| Jul 21, 2025 | Rozek Elizabeth | General Counsel And CCO | Sell | 10,780 | $9.13 | $98,470.99 | -5.5% | -11.3% | -13.4% | |
| Jul 23, 2024 | Kemble George | Executive Chairman | Sell | 23,625 | $3.17 | $74,829.83 | -16.6% | +70.3% | +193.3% | |
| Jul 19, 2024 | Martins Eduardo Bruno | Chief Medical Officer | Sell | 8,357 | $3.10 | $25,910.04 | -9.3% | +74.8% | +204.5% | |
| Jul 19, 2024 | Rozek Elizabeth | General Counsel And CCO | Sell | 10,914 | $3.10 | $33,830.13 | -6.4% | +74.8% | +204.5% |